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INTRODUCTION
Increased left atrial (LA) size is associated with poor
cardiovascular outcomes such as the development of heart
failure, atrial fibrillation (AF), and stroke in the elderly,
even in cases in which sinus rhythm is maintained [1].
There is already strong evidence for an association
between AF and ischemic stroke, and the majority of these
strokes occurred in patients who presented with sinus
rhythm [2]. Therefore, increased LA size has been
suggested to be related to stroke in elderly people with
sinus rhythm [3].
LA size is regarded as a reflection of the average effect of
the left ventricular (LV) filling pressures against the LA
over time and has been proposed as a surrogate marker of
diastolic burden [4]. In addition, increased LV filling
pressure resulting from a decrease in myocardial con-
tractility or impairment of myocardial relaxation is
considered the main pathophysiological factor involved
in heart failure and contributes to enlargement of the LA
[5]. To minimize the impact of LV filling pressure on LA
size, the present study was performed in subjects pre-
senting with preserved left ventricular systolic function
(LVSF).
The present study was conducted to re-evaluate the
relationship between LA size and stroke in subjects of all
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Background/Aims: Increased left atrial (LA) size has been proposed as a predictor of poor cardiovascular
outcome in the elderly. In the present study, we evaluated the relationship between LA size and stroke in
subjects of all ages who presented with preserved left ventricular systolic function (LVSF) and sinus rhythm (SR),
and investigated the relationships between LA size and other echocardiographic parameters of diastolic function.
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Mitral inflow pattern and E & A velocity showed no significant relationship with stroke (p=NS, p=NS,
respectively). Left ventricular mass index and LA dimension were significantly related to stroke (p=0.003,
p=0.023, respectively), and hypertension showed a marginal relationship with stroke (p=0.050). Age was not
related to stroke in the present study (p=NS).
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prevention of stroke in patients with preserved LVSF and SR should be considered in cases of LA enlargement.
(Korean J Intern Med 2009;24:24-32)
Keywords: Left atrium; Stroke; Echocardiography
Received: May 14, 2008
Accepted: September 10, 2008
Correspondence to Byung Chun Jung, MD
Department of Cardiology, Fatima General Hospital, 302-1 Shinam-dong, Dong-gu, Daegu 701-724, Korea  
Tel: 82-53-940-7214 / 82-53-940-7459, Fax: 82-53-954-7417, E-mail: augustjbc@yahoo.co.krages, not just the elderly, who presented with preserved
LVSF and sinus rhythm, and to investigate the rela-
tionships between LA size and other echocardiographic
parameters of diastolic function in these subjects. 
METHODS
Subjects
A total of 472 eligible subjects (161 men and 311 women)
were enrolled in this study between August 2006 and
February 2007. The stroke group (n=75) consisted of
cases of newly diagnosed first ischemic stroke attack
confirmed by computer tomography or magnetic
resonance imaging. The control group (n=397) consisted
of healthy participants identified in an annual health
evaluation program. Subjects with a LV ejection fraction
<50% and valvular heart disease presenting with greater
than mild insufficiency of the aortic or mitral valve, with
any degree of stenosis of the valves, or with structural
abnormalities were excluded from the present study.
Patients with a history of coronary artery disease or Q-
wave on surface ECG were also excluded.
Assessment of cardiovascular risk factors
Clinical data were obtained by a comprehensive review
of each patient’s medical record. Cardiovascular disease
(CVD) risk factors adopted for the scoring method used in
the Framingham Heart Study [6] were investigated for
each patient based on age, gender, history of systemic
hypertension, diabetes mellitus, hyperlipidemia, and
smoking (Table 1). Systemic hypertension was defined by
prior documentation of the clinical diagnosis or by
evidence of elevated systolic blood pressure of 140 mmHg
and/or diastolic blood pressure of 90 mmHg on two
occasions, in the absence of acute medical illness. Diabetes
mellitus was based on prior clinical documentation of the
condition, regardless of whether the patient was being
managed with dietary therapy, oral hypoglycemic agents,
and/or insulin. Hyperlipidemia was defined by a fasting
total cholesterol level >240 mg/dL and/or low-density
lipoprotein cholesterol level >160 mg/dL on two
occasions, or the use of cholesterol-lowering drugs. Current
smoking was referred to as the active use of tobacco
products at the time of enrollment in the study. 
Echocardiographic examination
LVSF was assessed using both the semiquantitative
visual estimation method and a modification of Simpson’s
method. Subjects with LVSF <50% on one or both me-
thods were excluded from the study. The wall motion
score index was also applied to exclude cases with regional
wall motion abnormalities. The index was calculated by
divid-ing the sum of the scores by the number of
visualized segments.
Mitral inflow was assessed by pulsed-wave Doppler
echocardiography from the apical four-chamber view,
with the Doppler beam aligned parallel to the direction of
flow and with a sample volume of 1-2 mm at the mitral
tips. From the mitral inflow profile, E- and A-wave veloci-
ties, E-deceleration time (DT), and the E/A ratio were
measured. Tissue Doppler imaging (TDI) from the apical
four-chamber view was also performed, with a sample
volume of 1-2 mm at the septal mitral annulus, to obtain
the ratio between transmitral early peak velocity and early
diastolic mitral annulus velocity, which was taken as the
E/E’ ratio. 
Diastolic filling patterns were categorized as normal,
impaired, or abnormal relaxation; pseudonormal; or
restrictive, according to previous studies [7,8]. First, the
mitral annular velocity was measured at the septal side
using TDI, to determine the E’/A’ ratio. The normal
pattern of diastolic filling was defined as both E/A and
E’/A’ ratios greater than 1. Cases in which the E’/A’ ratio
and E’ velocity were less than 1 and 7 cm/s, respectively,
were defined as showing the abnormal relaxation pattern
if the E/A ratio was less than 1, or the pseudonormal
pattern if the E/A ratio was greater than 1 and less than 2. 
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Table 1. Cardiovascular risk score
Number of points
Parameter Male Female
Age (years)
<34 -1 -9
35-39 0 -4
40-44 1 0
45-49 2 3
50-54 3 6
55-59 4 7
60-64 5 8
65-69 6 8
>70 7 8
History of hyperlipidemia 2 2
History of diabetes mellitus 2 4
History of systemic hypertension 2 2
Current smoker 2 2
This cardiovascular disease risk scoring table is a modification of
the Framingham risk score system proposed by Wilson et al. [6]LA size was assessed at end systole, just before the
frame preceding mitral valve opening. The LA dimension
was measured using its anteroposterior dimension
obtained from the parasternal long axis view [9]. Based on
the suggestion of Devereux et al. [10], the following
equation was applied to determine the LV mass in g,
where the mass can be determined from the LV short-axis
dimension using a simple geometric cubic formula
without measuring the major axis of the LV:
LVmass = 0.8×1.04[(LVID+PWT+IVST)
3-LVID
3]+0.6,
where LVID is the LV internal dimension, PWT is the
posterior wall thickness, and IVST is the interventricular
septal thickness. The LV mass index was obtained by
dividing the LV mass by the body surface area.
Statistical analysis
To evaluate the association between stroke event and
LA size, the data were classified into continuous variables
(clinical and echocardiographic data) and categorical
variables (CVD risk factors). Data for continuous variables
are expressed as the means±SD. All measurements in the
stroke and control groups were compared using an
unpaired, two-tailed Student’s t-test (SPSS version 12;
SPSS Inc., Chicago, IL). Data were compared between
subgroups within the stroke group and controls by one-
way ANOVA. The values of the categorical variables were
tested using the χ
2 test. A value of p<0.05 was considered
statistically significant.
To determine the relationships between LA size and the
categorical and continuous variables that showed
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CVD risk factor
χ
2 test 
(Stroke vs. Control)
Hyperlipidemia (%) 5 (15.2) 11 (26.2) 16 (21.3) 39 (30.5) 66 (24.5) 105 (26.5) NS NS NS
Diabetes mellitus (%) 9 (27.3) 10 (23.8) 19 (25.3) 30 (23.4) 39 (14.5) 69 (17.4) NS NS NS
Hypertension (%) 17 (51.5) 24 (57.1) 41 (54.7) 53 (41.4) 88 (32.7) 141 (35.5) NS 0.005 0.006
Current smoking (%) 12 (36.4) 3 (7.1) 15 (20) 57 (44.5) 12 (4.5) 69 (17.4) NS NS NS
Family history (%) 0 (0) 0 (0) 0 (0) 0 (0) 1 (0.4) 1 (0.3) NS NS NS
Framingham RF score* 8.1±2.1 10.7±2.5 9.5±2.6 8.4±2.4 9.7±2.3 9.3±2.4 NS 0.012 NS
M, male subjects; F, female subjects; BSA, body surface area; BMI, body mass index; CVD, Cardiovascular disease; LA, left atrium;
LVEF, left ventricular ejection fraction; DT, deceleration time; LVMI, left ventricular mass index. LA dimension was measured by M-
mode echocardiography. 
*Student’s t-test.
Echocardiographic
parameter
LA dimension (cm) 3.92±0.61 3.76±0.41 3.83±0.52 3.65±0.44 3.54±0.45 3.57±0.45 0.021 0.004 <0.0001
LVEF (%) 64.4±5.6 63.7±6.8 64.1±6.3 64.1±5.3 63.5±5.7 63.7±5.6 NS NS NS
Mitral peak E (cm/s) 68.3±19.2 77.1±20.1 73.2±20.0 71.1±15.7 69.9±17.5 70.3±16.9 NS 0.017 NS
Mitral peal A (cm/s) 77.2±15.9 96.1±20.6 87.9±20.8 83.0±21.4 85.8±18.5 84.9±19.5 NS 0.001 NS
E/A ratio 0.90±0.29 0.82±0.27 0.86±0.28 0.89±0.27 0.84±0.24 0.86±0.26 NS NS NS
DT (ms) 236±45 245±68 241±59 229±49 228±43 228±45 NS NS NS
E/E’ ratio 11.1±3.7 15.7±8.6 13.7±7.3 9.9±2.6 12.3±3.7 11.5±3.5 0.043 0.013 0.013
LV mass (g) 179±42 169±48 174±46 161±31 144±29 150±31 0.009 0.001 <0.0001
LV mass/height (g/m) 105±26 110±31 108±29 97±19 95±19 96±19 0.044 0.006 0.001
LVMI (g/m
2) 100±24 111±30 106±28 93±17 96±18 95±18 NS 0.003 0.001
Table 2. Baseline characteristics of the study population
Stroke Control p value
Parameter
M F Total M F Total
M F Total
(n=33) (n=42) (n=75) (n=128) (n=269) (n=397)
Clinical parameter
Student’s t-test 
(Stroke vs. Control)
Age (years) 64.5±5.0 65.7±5.0 65.2±5.1 65.0±5.6 65.8±6.0 65.6±5.9 NS NS NS
BSA (m
2) 1.76±0.11 1.51±0.12 1.61±0.17 1.73±0.12 1.50±0.10 1.58±0.15 NS NS NS
BMI (kg/m
2) 24.1±2.4 23.4±2.3 23.6±2.3 23.6±2.6 24.3±2.9 24.0±2.9 NS NS NS
Height (m) 1.67±0.05 1.53±0.06 1.59±0.09 1.66±0.05 1.51±0.06 1.56±0.09 NS NS NS
Weight (kg) 67.8±8.2 54.7±7.2 60.3±10.0 65.2±8.0 55.5±6.9 58.7±8.7 NS NS NSsignificance in the χ
2 test between the stroke and control
groups or in the univariate correlation analysis between
significant parameters and LA dimension, logistic
regression or linear regression analyses were performed,
respectively. Univariate analysis of variance (general
linear model) was applied to evaluate the degree of
association between stroke and LA size, in addition to the
above variables that indicated significant differences
between the stroke and control groups or a significant
relationship with the LA dimension on regression
analysis. Significance was defined as p<0.05 for all analy-
ses.
RESULTS
The mean age was 65.2±5.1 years in the stroke group
and 65.6±5.9 years in the control group. There was no
difference in mean age between the two groups, which
were reclassified by gender. Other clinical parameters
such as body surface area (BSA), body mass index (BMI),
height, and weight were not significantly different
between the stroke and control groups (Table 2, upper
panel). Therefore, the possible bias for the LA dimension,
which may occur due to differences in clinical parameters
between the groups, was considered too minimal to affect
the results of the present study.
Regression analysis indicated that the clinical
parameters, with the exception of age, showed weak
positive correlations with LA dimension (BSA: r=0.290,
p<0.0001; BMI: r=0.290, p<0.0001; height: r=0.287,
p=0.002; weight: r=0.154, p<0.0001). Univariate analysis
of variance revealed significant relationships of LA
dimension with stroke and age, but no significant
relationships of LA dimension with the other clinical
parameters or gender (Table 3, upper panel).
Relationships between the LA dimension and
cardiovascular risk factors
The incidences of systemic hypertension, diabetes
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Table 3. Statistical analyses of clinical and echocardiographic parameters and CVD risk factors with LA dimension
Linear regression analysis with LA dimension General linear model with LA dimension
Parameter β FR
2 p value F p value
Clinical parameter 9.918* 0.000*
Age 0.051 1.244 0.003 NS 6.797 0.009
BSA 0.290 36.807 0.084 0.0001 1.636 0.202
BMI   0.287 33.473 0.077 0.0001 1.086 0.298
Hight   0.154 9.653 0.024 0.002 2.355 0.126
Weight   0.332 50.675 0.110 0.0001 0.314 0.576
Stroke event - - - - 10.210 0.002
Gender - - - - 0.77 0.782
Echocardiographic parameter 10.977* 0.000*
E/E’ ratio 0.123 4.778 0.015 0.030 1.328 0.250
LV mass  0.396 57.512 0.157 0.0001 0.104 0.748
LV mass/hight  0.383 44.169 0.147 0.0001 4.007 0.046
LVMI 0.333 32.025 0.111 0.0001 7.613 0.006
Hypertension - - - - 0.165 0.685
Logistic regression analysis with LA dimension General linear model with LA dimension
Odds ratio 95% CI p value F p value
CVD risk factor 4.531* 0.000*
Hypertension 1.820 1.204-2.751 0.005* 5.215 0.023
Stroke event 3.394 1.912-6.025 0.0001* 13.192 0.000
Gender - - - 3.372 0.067
Framingham risk score χ
2 dF p value
Total 13.900 11 0.239 0.919 0.522
Stroke group 12.315 11 0.340 - -
Control group 15.456 11 0.163 - -
BSA, body surface area; BMI, body mass index; LA, left atrium; CVD, cardiovascular disease; LV, left ventricle; LVMI, left ventricular
mass index. 
*Corrected model significance of general linear model, a type of univariate analysis of variance.mellitus, hyperlipidemia, and smoking were determined
and compared between the stroke and control groups.
There were no significant differences in the incidences of
these CVD risk factors between the two groups, with the
exception of hypertension, which showed a difference only
in women (stroke vs. control: 57.1% vs. 32.7%; p=0.005;
Table 2, lower panel). Therefore, univariate analysis of
variance was performed to determine the relationship
between stroke and LA dimension, using hypertension as
a fixed factor. The LA dimension was strongly related to
stroke, while a lesser relationship was seen with the
history of hypertension (p<0.0001, p=0.023, respectively;
Table 3, lower panel).
This study did not find a significant difference between
the stroke and control groups with regard to the Framingham
risk score (9.5±2.6 vs. 9.3±2.4, respectively; p=0.388). When
the patients were regrouped according to gender, the
Framingham risk scores for men did not differ between
the stroke and control groups (8.1±2.1 vs. 8.4±2.4, respec-
tively; p=0.46), whereas the scores for women did differ
between the two groups (10.7±2.5 vs. 9.7±2.3, respec-
tively; p=0.012). This finding was considered to be due to
the relatively high incidence of hypertension among
women in the stroke group in our study population (Table
2). Univariate analysis of variance revealed no association
between the Framingham risk scores and LA dimension.
The Framingham risk scores have been shown to be
associated with various cardiovascular outcomes, but the
scores did not directly reflect the anatomical changes of
the LA in the present study.
Echocardiographic parameters in the stroke and
control groups
The LA dimension of the stroke group (3.83±0.52 cm)
was significantly greater than that of the control group
(3.57±0.45 cm; p<0.0001). The LA dimension was
greater in men than in women (3.70±0.49 vs. 3.57±0.46
cm, respectively; p=0.003) and was greater in men and
women, respectively, of the stroke group compared with
the corresponding controls (men: 3.92±0.61 vs. 3.65±0.44
cm, p=0.021; women: 3.76±0.41 vs. 3.54±0.45 cm,
p=0.004). The LVEF of the stroke group was not sign-
ificantly different from that of the controls, and the LVEF
in men and women, respectively, did not differ between
the stroke and control groups (Table 2, middle panel).
Peak E and A velocity of the mitral inflow were similar
between the men of the stroke and control groups, but
differed significantly between the women of the stroke
versus control groups. The E/E’ ratio, LV mass, LV mass
/height, and LV mass index were significantly greater in
the stroke group than in the control group. The E/A ratio
and DT were not significantly different between the two
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Table 4. Echocardiographic parameters depending on the presence or absence of stroke 
Stroke Control
Parameter
Hypertensive Normtensive p value Hypertensive Normotensive p value
(n=41) (n=32) (n=141) (n=239)
LA dimension (cm) 3.90±0.5 3.74±0.46 0.183 3.64±0.45 3.55±0.46 0.051
E/E’ ratio 12.7±3.6 14.6±10.3 0.334 11.9±3.9 11.3±3.3 0.083
LV mass (g) 176±45 170±46 0.566 156±29 146±31 0.003*
LV mass/hight (g/m) 111±28 104±30 0.360 100±18 93±19 0.001*
LVMI (g/m
2) 110±28 102±30 0.233 99±17 93±18 0.003*
LA, left atrium; LV, left ventricle; LVMI, left ventricular mass index. 
*Statistically significant.
Table 5. Echocardiographic parameters depending on the presence or absence of hypertension
Hypertensive Normotensive
Parameter
Stroke Control p value Stroke Control p value
(n=41) (n=32) (n=141) (n=239)
LA dimension (cm) 3.90±0.54 3.74±0.45 0.002* 3.74±0.46 3.55±0.46 0.026*
E/E’ ratio 12.7±3.6 11.9±3.9 0.238 11.3±3.3 11.3±3.3 0.97
LV mass (g) 176±45 156±29 0.009* 146±31 146±31 0.008*
LV mass/height (g/m) 111±28 100±18 0.023* 93±19 93±19 0.66
LVMI (g/m
2) 110±28 99±17 0.017* 93±18 93±18 0.112
LA, left atrium; LV, left ventricle; LVMI, left ventricular mass index. 
*Statistically significant.groups. On regression analysis, these four echocar-
diographic parameters showed significant linear
relationships with the LA dimension. Univariate analysis
of variance using these four parameters and hypertension
taken together indicated that the LV mass index was most
closely associated with the LA dimension (p=0.006),
followed by the LV mass/height (p=0.046). The LV mass
and the values of the E/E’ ratio did not show any
association with the LA dimension (Table 3, middle panel).
To estimate the effects of hypertension on the LA
dimension, the subjects were further divided into two
subgroups according to the presence or absence of a
previous history of hypertension. For both the stroke and
control groups, the LA dimension did not show a
significant difference between subjects who did and did
not have a history of hypertension (Table 4). However, the
LA dimension of the stroke group was greater than that of
the control group regardless of a history of hypertension
(Table 5). In the absence of a history of hypertension, the
LV mass for the stroke group was greater than that for the
controls (170±46 g vs. 146±31 g, respectively; p=0.008);
however, LV mass/height and the LV mass index of the
stroke group were not greater than those of the controls.
Univariate analysis of variance indicated that the LV mass
index showed a closer association with LA dimension than
with the LV mass or LV mass/height (corrected model
F=11.114, p<0.0001, p<0.0001, p=0.879, and p=0.004,
respectively). In cases with a history of hypertension, the
LV mass, LV mass/ height, and LV mass index of the
stroke group were greater than those of the controls
(176±45 g vs. 156±29 g, p=0.009; 111±28 vs. 100±18,
p=0.023; and 110±28 vs. 99±17, p=0.017). Only the LV
mass index, and not the LV mass or LV mass/height,
showed an association with the LA dimension in the
univariate analysis (corrected model F=17.311, p<0.0001,
p=0.021, p=0.270, and p=0.131, respectively). Consequently,
it was concluded that regardless of a history of hyper-
tension, the LA dimension in the stroke group was greater
than that in the control group, and the LV mass index had
a positive relationship with the LA dimension in both the
stroke and control groups.
Thus, the LA dimension was significantly associated
with the LV mass index and stroke but not with hyper-
tension.
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Table 6. Characteristics of mitral inflow patterns in stroke and control groups
Stroke (n=75) Control (n=397)
Parameter Normal Abnormal Pseudo-normal Normal Abnormal Pseudo-normal
Number (%) 6 (8) 59 (78.7) 10 (13.3) 30 (7.6) 302 (76.1) 65 (16.3)
Men (%) 3 (4) 23 (30.7) 7 (9.3) 13 (3.3) 90 (22.7) 25 (6.3)
(n=161)
Women (%) 3 (4) 36 (48) 3 (4) 17 (4.3) 212 (53.4) 40 (10)
(n=311)
Age (years) 62.2±4.8 65.6±5.3* 64.5±3.2* 61.3±5.0 66.7±5.7* 62.4±5.3
LA dimension (cm)  4.10±0.93* 3.80±0.45* 3.87±0.57* 3.59±0.36 3.58±0.46 3.55±0.47
LV mass (g) 191±68* 170±44* 186±41* 147±31 150±31 150±29
LV mass/height (g/m) 118±41* 107±28* 109±23* 91±19 97±19 95±16
LVMI (g/m
2) 116±42* 106±28* 106±23* 91±17 96±18 93±15
LA, left atrium; LV, left ventricle; LVMI, left ventricular mass index. 
The χ
2 test was used for analysis of incidence, and ANOVA was used for comparison of means.
*Significantly different between subgroups on post hoc analysis.
Table 7. Statistical analyses of predictors of stroke
Parameter Odds ratio 95% CI p value
LVMI 1.021 1.007-1.035 0.003*
LA dimension  2.081 1.106-3.917 0.023*
Hypertension 0.581 0.338-0.999 0.050*
Age 0.997 0.931-1.025 0.344
LA, left atrium; LVMI, left ventricular mass index.
LVMI, LA dimension, hypertension, and age were used simultaneously as covariates. 
*Statistically significant. Characteristics of the mitral LV inflow pattern in
the stroke and control groups
As our study population only included cases with
preserved LVSF and sinus rhythm, impaired and
abnormal relaxation patterns of mitral LV inflow were the
most commonly observed patterns in both groups, with
no cases showing the restrictive pattern. The incidences of
each mitral inflow pattern were not different between the
stroke and control groups, and the association between an
abnormal relaxation pattern and advanced age is well
known (Table 6). Regardless of the mitral inflow pattern,
the LA dimension of the stroke group was significantly
greater than that of the controls. The same results were
observed for the LV mass, LV mass/height, and LV mass
index. Univariate analysis indicated that there was no
association between the mitral inflow pattern and either
the LA dimension or stroke (F=1.122, p=0.327; F=0.218,
p=0.804, respectively).
Relationship of stroke with LA dimension, age,
and LV mass index
The above results indicate that the LA dimension has
clear associations with age, stroke, and LV mass index,
and a marginal relationship with history of hypertension,
in a univariate analysis of variance. In a logistic regression
analysis for stroke performed with these interrelated
parameters, the LV mass index and LA dimension showed
significant relationships with stroke (Odds ratio=1.021,
95% CI=1.007-1.035, p=0.003; and Odds ratio=2.081,
95% CI=1.106-3.917, p=0.023, respectively). Hypertension
showed a marginal relationship with stroke (Odds
ratio=0.581, 95% CI=0.338-0.999, p=0.050), and age was
not related to stroke in the present study (Odds
ratio=0.997, 95% CI=0.931-1.025, p=0.344) (Table 7). 
DISCUSSION
Previous studies have identified a number of echocar-
diographic variables, including the LA dimension, as
being of independent clinical value for predicting the
likelihood of CVD events and overall mortality. However,
with regard to the relationship between the LA dimension
and stroke, most studies have been performed in
heterogeneous populations or in subjects with established
CVD such as myocardial infarction, abnormal LVEF, or
atrial fibrillation. Although the Framingham Heart Study
[11] had a prospective design and was able to determine
the relationship between the LA dimension and stroke,
the systemic hypertension criteria used were markedly
different from those used in the present study. Previously,
hypertension was considered to be present when the
systolic pressure was above 160 mmHg or the diastolic
pressure was above 95 mmHg. The Cardiovascular Health
Study [12], which also reported a relationship between the
LA dimension and stroke, was performed only in subjects
older than 65 years. The Stroke Prevention in Atrial
Fibrillation Study supported an association between
stroke and LA enlargement [13], whereas two other cohort
trials examining this issue did not show such a clear
relationship, even after enrolling exclusively cases with
atrial fibrillation [14,15]. Recently, Barnes et al. (3)
reported that the LA dimension is related to the first
ischemic stroke in people older than 65 years. However,
the relationship between the LA dimension and stroke has
not been investigated in detail in subjects with preserved
LVSF and sinus rhythm and without overt CVD or in
those of relatively young age. The present case-control
study in such subjects showed that an increase in the LA
dimension by itself has a clear relationship with stroke in
subjects presenting with preserved LVSF and normal
sinus rhythm; thus, neither an age older than 65 years or
compromised LVSF with obvious CVD is a requirement
for the relationship between the LA dimension and stroke.
Mechanism behind the relationship between
stroke and the LA dimension
The mechanisms underlying the relationship between
stroke and an enlarged LA are not completely understood.
The most plausible hypothesis is that LA dilatation
promotes stasis of blood, which in turn results in a
propensity for thrombus formation and increased risk of
embolism. The thrombogenicity of a dilated left atrium
has been supported by the results of several trans-
esophageal echocardiographic studies showing an asso-
ciation between an enlarged left atrium and spontaneous
echocardiographic contrast [16-18].
Alternatively, the LA enlargement may be a surrogate
marker representing an adaptive response to some
variously caused endothelial dysfunction that affects the
systemic vascular bed. Endothelial dysfunction results
from the abnormal regulation of and response to many
different cytokines and paracrine hormones, including
nitric oxide, angiotensin II and its receptor, plasminogen
inhibitor I, thrombomodulin, and endothelin [19]. In
particular, angiotensin II and its receptor are well-known
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myocardial electrical coupling in the atrium, resulting in
atrial dilatation and thromboembolism [20,21]. In the
Losartan Intervention for End Point Reduction in
Hypertension study, losartan significantly decreased the
incidence of stroke in comparison with atenolol [22].
Left atrial enlargement has frequently been associated
with more severe cases of congestive heart failure,
myocardial infarction, and systemic hypertension, and
with chronic atrial fibrillation. Nevertheless, it is note-
worthy that the relationship between stroke and LA
dimension was also observed in the present study, in
which the subjects had preserved LVSF and normal sinus
rhythm without evidence of CVD. It may be that LA
enlargement promotes the development of asymptomatic
interim atrial fibrillation, which in turn places the patient
at increased risk for stroke.
Relationship of LV mass index with LA dimension
and stroke
Left atrial enlargement and left ventricular hypertrophy
are manifestations of cardiac target organ damage in
patients with established hypertension [23]. In an analysis
of the Framingham Heart Study cohort, Bikkina et al. [24]
reported that increased LV mass predicts stroke. Even
after adjustment for LV mass index and systemic hyper-
tension, the LA dimension still maintained its relationship
with stroke in the present study. Furthermore, the rela-
tionship was also observed in cases without hypertension.
These findings suggest that the relationship cannot be
completely accounted for by LV mass and arterial blood
pressure and that LA enlargement may serve as a surro-
gate marker for other unidentified risk factors for stroke.
Limitations and clinical implications
Echocardiographic examinations using the M-mode
have a tendency to intrinsically miscalculate the LA
dimension. In the present study, the LA dimension did
not increase markedly according to the deterioration of
the mitral inflow pattern, and the incidence of the
pseudonormal pattern was greater than that reported
previously [25]. Therefore, to resolve these issues, further
studies that include the measurement of LA volume in a
larger study population are required. The potential for
bias was reduced by the routine assessment of echocar-
diograms in a blind manner with regard to subject charac-
teristics. Even with the clear association between stroke
and LA dimension demonstrated in the present case-
control study, further prospective cohort investigations
are needed to determine a cause and effect relationship.
The results of the present study indicated that the LA
dimension was significantly related to the incidence of
stroke. Although this relationship was somewhat
attenuated after adjusting for LV mass index, it remained
significant, and we suggest that strategies for the
prevention of stroke in patients with sinus rhythm should
be considered in cases with LA enlargement. It is also
necessary to investigate the mechanism underlying the
above relationship in order to improve the management of
patients in such clinical conditions. 
REFERENCES
1. Abhayaratna WP, Seward JB, Appleton CP, et al. Left atrial size:
physiologic determinants and clinical applications. J Am Coll
Cardiol 2006;47:2357-2363.
2. American Heart Association. Heart disease and stroke statistics;
2005 update. Dallas, American Heart Association, 2003.
3. Barnes ME, Miyasaka Y, Seward JB, et al. Left atrial volume in
the prediction of first ischemic stroke in an elderly cohort without
atrial fibrillation. Mayo Clin Proc 2004;79:1008-1014.
4. Douglas PS. The left atrium: a biomarker of chronic diastolic
dysfunction and cardiovascular disease risk. J Am Coll Cardiol
2003;42:1206-1207.
5. Tsang SM, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Left
atrial volume as a morphophysiologic expression of left
ventricular diastolic dysfunction and relation to cardiovascular
risk burden. Am J Cardiol 2002;90:1284-1289.
6. Wilson PWF, D’Agostino RB, Levy D, Belanger AM, Silbershatz
H, Kannel WB. Prediction of coronary heart disease using risk
factor categories. Circulation 1998;97:1837-1847.
7. Nishimura RA, Tajik AJ. Evaluation of diastolic filling of left
ventricle in health and disease: Doppler echocardiography is the
clinician’s Rosetta Stone. J Am Coll Cardiol 1997;30:8-18.
8. Oh JK, Appleton CP, Hatle LK, Nishimura RA, Seward JB, Tajik
AJ. The noninvasive assessment of left ventricular diastolic
function with two-dimensional and Doppler echocardiography. J
Am Soc Echocardiogr 1997;10: 246-270.
9. Basnight MA, Gonzalez MS, Kershenovich SC, Appleton CP.
Pulmonary venous flow velocity: relation to hemodynamics,
mitral flow velocity and left atrial volume, and ejection fraction. J
Am Soc Echocardiogr 1991;4:547-558.
10. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic
assessment of left ventricular hypertrophy: comparison to
necropsy findings. Am J Cardiol 1986;57:450-458.
11. Benjamin EJ, D’Agostino RB, Belanger AJ, Wolf PA, Levy D. Left
atrial size and the risk of stroke and death. Circulation 1995;
92:835-841.
Kim BS, et al. Relationship between left atrial size and stroke 3112. Tell GS, Fried L, Hermanson B, Manolio TA, Newman AB,
Borhani NO. Recruitment of adults 65 years and older as
participants in the Cardiovascular Health Study. Ann Epidemiol
1993;3:358-366.
13. The Stroke Prevention in Atrial Fibrillation Investigators.
Predictors of thromboembolism in atrial fibrillation: II.
echocardiographic features of patients at risk. Ann Intern Med
1992;116:6-12.
14. The Boston Area Anticoagulation Trial for Atrial Fibrillation
Investigators. The effect of low-dose warfarin on the risk of stroke
in patients with nonrheumatic atrial fibrillation. N Engl J Med
1990;323:1505-1511.
15. Petersen P, Kastrup J, Helweg-Larsen S, Boysen G, Godtfredsen
J. Risk factors for thromboembolic complications in chronic
atrial fibrillation. Arch Intern Med 1990;150:819-821.
16. Lee RJ, Bartzokis T, Yeoh TK, Grogin HR, Choi D, Schnittger I.
Enhanced detection of intracardiac sources of cerebral emboli by
transesophageal echocardiography. Stroke 1991;22:734-739.
17. Daniel WG, Nellessen U, Schröder E, et al. Left atrial spon-
taneous echo contrast in mitral valve disease: an indicator for an
increased thromboembolic risk. J Am Coll Cardiol 1988;11:1204-
1211.
18. Cujec B, Polasek P, Voll C, Shuaib A. Transesophageal echocar-
diography in the detection of potential cardiac source of embolism
in stroke patients. Stroke 1991;22:727-733.
19. LinksYamashita T, Sekiguchi A, Kato T, et al. Angiotensin type 1
receptor blockade prevents endocardial dysfunction of rapidly
paced atria in rats. J Renin Angiotensin Aldosterone Syst
2007;8:127-132.
20. Sun Y, Ramires FJ, Weber KT. Fibrosis of atria and great vessels
in response to angiotensin II or aldosterone infusion. Cardiovasc
Res 1997;35:138-147.
21. Casaclang-Verzosa G, Gersh BJ, Tsang TS. Structural and
functional remodeling of the left atrium: clinical and therapeutic
implications for atrial fibrillation. J Am Coll Cardiol 2008;51:1-11.
22. Wachtell K, Hornestam B, Lehto M, et al. Cardiovascular mor-
bidity and mortality in hypertensive patients with a history of
atrial fibrillation. J Am Coll Cardiol 2005;45:705-711.
23. Miller JT, O’Rourke RA, Crawford MH. Left atrial enlargement:
an early sign of hypertensive heart disease. Am Heart J
1988;116:1048-1051.
24. Bikkina M, Levy D, Evans JC, et al. Left ventricular mass and risk
of stroke in an elderly cohort. JAMA 1994;272:33-36.
25. Bursi F, Weston SA, Redfield MM, et al. Systolic and diastolic
heart failure in the community. JAMA 2006;296:2209-2216.
32 The Korean Journal of Internal Medicine Vol. 24, No. 1, March 2009